It is therefore likely that the binding of tumor cell-derived TRAIL in TRAIL-R4-KD cells to TRAIL-R1/R2 results in a constitutively increased activity of caspases, which is too weak to induce cell death, but strong enough to activate ERK. Here, TNFRSF10D is linked to neoplasm.